Press releases
- Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
- Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
- Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
- Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
- Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
More ▼
Key statistics
As of last trade, Adicet Bio Inc (1IJA:BER) traded at 1.39, 37.12% above the 52 week low of 1.01 set on Nov 29, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.34 |
---|---|
High | 1.43 |
Low | 1.33 |
Bid | 1.32 |
Offer | 1.45 |
Previous close | 1.36 |
Average volume | 12.11 |
---|---|
Shares outstanding | 82.17m |
Free float | 81.00m |
P/E (TTM) | -- |
Market cap | 115.86m USD |
EPS (TTM) | -3.32 USD |
Data delayed at least 15 minutes, as of May 03 2024 16:12 BST.
More ▼